Stay updated on Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial
Sign up to get notified when there's something new on the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page.

Latest updates to the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA new frontend revision v3.5.0 is implemented, replacing the previous revision v3.4.3.SummaryDifference0.0%

- Check16 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedThe page shows a new revision number (v3.4.2) replacing the previous (v3.4.1). This appears to be a software maintenance update with no visible changes to the study details or functionality.SummaryDifference0.0%

- Check51 days agoChange Detected- Footer revision updated from v3.4.0 to v3.4.1; a minor maintenance change that does not affect study details.SummaryDifference0.0%

- Check58 days agoChange DetectedA 'Show glossary' option was added to the page. Revision information was updated to v3.4.0, replacing v3.3.4 and updating capitalization of related labels.SummaryDifference0.2%

- Check72 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4. No visible changes to study details or eligibility criteria.SummaryDifference0.0%

Stay in the know with updates to Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page.